New Lancet Phase III Study Shows Proton Therapy Significantly Improves Survival and Reduces Toxicity in Head and Neck Cancers
Ten percent higher 5-year overall survival rates in patients receiving precise proton therapy vs. traditional radiation therapy Patients…
